Related Experiment Video
Updated: Jun 10, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Effective cardiac disease classification using FS-XGB and GWO approach
Daphin Lilda S1, Jayaparvathy R1
1Dept. of Electrical and Electronics Engineering, Sri Sivasubramaniya Nadar College of Engineering, Chennai, India.
Insights
This study introduces a novel machine learning approach using grey wolf optimization for feature selection in electrocardiogram (ECG) analysis, significantly improving cardiovascular disease (CVD) detection accuracy with fewer features.
Area of Science:
- Cardiology
- Biomedical Engineering
- Artificial Intelligence
Background:
- Cardiovascular diseases (CVDs) are a major global health concern, necessitating early detection.
- Machine learning (ML) algorithms analyzing electrocardiogram (ECG) signals show promise for CVD prediction.
- Effective ML models require significant feature extraction and selection from ECG data to enhance performance and reduce overfitting.
Purpose of the Study:
- To develop an efficient ML model for identifying five types of CVDs using ECG features.
- To employ Grey Wolf Optimization (GWO) for selecting a reduced, optimal feature set from ECG signals.
- To evaluate a novel feature-specific extreme gradient boosting (FS-XGB) classifier against other ML methods.
Main Methods:
- Extraction of pertinent features from ECG signals.
- Application of Grey Wolf Optimization (GWO) for feature selection, reducing dimensionality.
- Development and implementation of a feature-specific extreme gradient boosting (FS-XGB) classifier.
- Comparative analysis of FS-XGB against Gradient Boosting, AdaBoost, Naïve Bayes, and SVM.
Main Results:
- The proposed FS-XGB model achieved a maximum classification accuracy of 98.8% using only seven optimal features.
- Exceptional performance metrics were recorded: 100% precision, 99.8% recall, 100% F1-score, and 98.8% AUC.
- The methodology significantly outperformed existing approaches in terms of feature reduction and predictive accuracy.
Conclusions:
- The GWO-based feature selection combined with FS-XGB offers a highly effective and efficient method for CVD detection from ECGs.
- This approach demonstrates the potential for improved diagnostic tools in cardiology through advanced ML techniques.
- The study highlights the importance of optimized feature selection for robust and accurate ML-based medical diagnoses.
Abstract:
Globally, cardiovascular diseases (CVDs) are a leading cause of death; however, their impact can be greatly mitigated by early detection and treatment. Machine learning (ML)-based algorithms that use features extracted from electrocardiogram (ECG) signals are known to provide good accuracy in predicting various CVDs. Thus, in order to build more effective and efficient machine learning models, it is necessary to extract significant features from ECGs. In order to reduce overfitting and training overhead and improve model performance even more, feature selection or dimensionality reduction is essential. In this regard, the current work uses the grey wolf optimization (GWO) technique to pick a reduced feature set after extracting pertinent characteristics from ECG signals in order to identify five different types of CVDs. On the basis of the feature relevance of the chosen features, a feature-specific extreme gradient boosting approach (FS-XGB) is also suggested. The suggested FS-XGB classifier's performance is contrasted with that of other machine learning techniques, including gradient boosting method, AdaBoost, naïve Bayes, and support vector machine (SVM). The proposed methodology achieves a maximum classification accuracy, precision, recall, F1-score, and AUC value of 98.8 %, 100 %, 99.8 %, 100 %, and 98.8 %, respectively, with just seven optimal features, significantly fewer than the number of features used in existing works.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

